Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
80 hedge funds and large institutions have $47M invested in Ampio Pharmaceuticals Inc. in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 9 closing their positions.
146% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 13
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
7% more funds holding
Funds holding: 75 → 80 (+5)
53% less call options, than puts
Call options by funds: $853K | Put options by funds: $1.82M
60% less capital invested
Capital invested by funds: $116M → $47M (-$69.1M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.28M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.49M |
| 3 |
Morgan Stanley
New York
|
+$1.07M |
| 4 |
IMS
Index Management Solutions
Philadelphia,
Pennsylvania
|
+$929K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$633K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$7.02M |
| 2 |
TC
Talkot Capital
Sausalito,
California
|
-$3.01M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.6M |
| 4 |
Millennium Management
New York
|
-$670K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$469K |
AMPE Hedge Fund Activity: Q3 2014 in Review
80 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2014, worth a combined $47M — down 60% from $116M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new AMPE positions and 9 closed out — a net gain of 6 holders — while 32 added to existing stakes and 13 trimmed.
The largest buyer was Knoll Capital Management, adding an estimated $2.28M. The largest seller was DAFNA Capital Management, cutting an estimated $7.02M.
- 80 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2014, up from 75 in Q2 2014.
- Funds reported $47M of Ampio Pharmaceuticals Inc. stock for Q3 2014, down 60% quarter-over-quarter.
- 15 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2014 and 9 closed out, a net change of +6 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2014 was Knoll Capital Management, an estimated $2.28M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2014 was DAFNA Capital Management, an estimated $7.02M sold.
Based on aggregated 13F filings for Q3 2014.